Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
4.8 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Medicaid participants; treatment involving the prescription of opioids, payment. | Medicaid participants; treatment involving the prescription of opioids; payment. Prohibits licensed providers from requiring payment from Medicaid participants for the prescription of an opioid for the management of pain or the prescription of buprenorphine-containing products, methadone, or other opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration for medication-assisted treatment of opioid addiction, regardless of whether the provider participates in the state plan for medical assistance. | us/states/va | Virginia General Assembly | 2022 | SB 594 | Virginia SB 594 (2022) |
|
enacted |
|
3 | 25 | 6 | 2022-01-12 | 2022-04-08 | openstates | ocd-bill/9727b688-3f38-4d36-b5e3-5352104917e7 | https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+SB594 | 6ed79162a501bdc046b43946b4676215d6ceaf543b618894fe0df3bb43957c93 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 594 (2022) — Medicaid participants; treatment involving the prescription of opioids, payment.
Medicaid participants; treatment involving the prescription of opioids; payment. Prohibits licensed providers from requiring payment from Medicaid participants for the prescription of an opioid for the management of pain or the prescription of buprenorphine-containing products, methadone, or other opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration for medication-assisted treatment of opioid addiction, regardless of whether the provider participates in the state plan for medical assistance.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0214 (committee substitute) — source
- Prefiled and ordered printed; offered 01/12/22 22103669D (committee substitute) — source
- SB594ER (committee substitute) — source
Votes
- Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Education and Health (15-Y 0-N) — 15–0 (pass) · upper
- VOTE: Passage (100-Y 0-N) — 99–0 (pass) · lower
- Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
- Passed Senate (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Health, Welfare and Institutions (19-Y 2-N) — 19–2 (pass) · lower
Sponsors
- Todd E. Pillion — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-01-12 Prefiled and ordered printed; offered 01/12/22 22103669D
introduction - 2022-01-12 Referred to Committee on Education and Health
referral-committee - 2022-01-21 Impact statement from DPB (SB594)
- 2022-01-31 Assigned Education sub: Health Professions
referral-committee - 2022-02-10 Reported from Education and Health (15-Y 0-N)
committee-passage - 2022-02-11 Constitutional reading dispensed (40-Y 0-N)
- 2022-02-14 Read second time and engrossed
reading-2 - 2022-02-14 Constitutional reading dispensed (40-Y 0-N)
- 2022-02-14 Passed Senate (40-Y 0-N)
passage - 2022-02-22 Placed on Calendar
- 2022-02-22 Read first time
reading-1 - 2022-02-22 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2022-02-24 Reported from Health, Welfare and Institutions (19-Y 2-N)
committee-passage - 2022-02-28 Read second time
reading-2 - 2022-03-01 Passed by for the day
- 2022-03-02 Read third time
reading-3 - 2022-03-02 Passed House (100-Y 0-N)
passage - 2022-03-02 VOTE: Passage (100-Y 0-N)
- 2022-03-07 Enrolled
- 2022-03-08 Impact statement from DPB (SB594ER)
- 2022-03-08 Signed by President
- 2022-03-08 Signed by Speaker
- 2022-03-22 Enrolled Bill Communicated to Governor on March 22, 2022
- 2022-03-22 Governor's Action Deadline 11:59 p.m., April 11, 2022
- 2022-04-08 Approved by Governor-Chapter 214 (effective 7/1/22)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/9727b688-3f38-4d36-b5e3-5352104917e7. Confidence: reported (aggregated from official Virginia legislature records).